Results 231 to 240 of about 364,170 (283)

Escherichia coli in the production of biopharmaceuticals

open access: yesBiotechnology and Applied Biochemistry, Volume 72, Issue 2, Page 528-541, April 2025.
Abstract Escherichia coli has shouldered a massive workload with the discovery of recombinant DNA technology. A new era began in the biopharmaceutical industry with the production of insulin, the first recombinant protein, in E. coli and its use in treating diabetes. After insulin, many biopharmaceuticals produced from E. coli have been approved by the
İbrahim İncir, Özlem Kaplan
wiley   +1 more source

Dual‐Stage Cross‐Flow Filtration: Integrated Capture and Purification of Virus‐Like Particles

open access: yesBiotechnology and Bioengineering, Volume 122, Issue 4, Page 884-894, April 2025.
An innovative dual‐stage cross‐flow filtration (CFF) setup is presented to capture and purify virus‐like particles (VLP). Coupling two CFF units and using a 2 µm/300 kDa MWCO membrane configuration allows for selective VLP precipitation and washing of the precipitate in the first membrane stage combined with subsequent, simultaneous recovery, isolation,
Annabelle Dietrich   +2 more
wiley   +1 more source

The Role of Cholesterol Metabolism and Its Regulation in Tumor Development

open access: yesCancer Medicine, Volume 14, Issue 7, April 2025.
ABSTRACT Background Within the tumor microenvironment, tumor cells undergo metabolic reprogramming of cholesterol due to intrinsic cellular alterations and changes in the extracellular milieu. Furthermore, cholesterol reprogramming within this microenvironment influences the immune landscape of tumors, facilitating immune evasion and consequently ...
Yongmei Wu   +5 more
wiley   +1 more source

Advances in the Prevention of Cervical Cancer by Anti‐Human Papillomavirus Agents

open access: yesCancer Medicine, Volume 14, Issue 7, April 2025.
ABSTRACT Background Cervical cancer remains a major global health threat for women, primarily driven by human papillomavirus (HPV) infection. While HPV vaccination serves as the cornerstone of prevention, disparities in vaccine accessibility persist across low‐income countries.
Hangdi Chen   +10 more
wiley   +1 more source

Immune response to hepatitis B vaccine among children under 5 years in Africa: a meta-analysis. [PDF]

open access: yesTrop Med Health
Olakunde BO   +6 more
europepmc   +1 more source

Fulminant Type 1 Diabetes Mellitus With Concomitant Coxsackievirus B6 Antibody Elevation and RNA‐Based COVID‐19 Vaccination: A Case Report and Review of the Literature

open access: yesClinical Case Reports, Volume 13, Issue 4, April 2025.
ABSTRACT Fulminant type 1 diabetes is a rare but severe condition that can develop rapidly, often in association with viral infections. In this case, coxsackievirus B6 antibody levels were elevated after disease onset, though its significance remains unclear.
Hisaka Minami   +10 more
wiley   +1 more source

Current Advancements in Serum Protein Biomarkers for Hepatitis B Virus‐Associated Hepatocyte Remodeling and Hepatocellular Carcinoma

open access: yesImmunity, Inflammation and Disease, Volume 13, Issue 4, April 2025.
ABSTRACT Background Hepatitis B virus (HBV)‐related liver cancer is the third most common cause of cancer‐related death globally. Hepatocyte remodeling, also known as hepatocyte transformation and immortalization, and hepatocellular carcinoma (HCC), are brought on by persistent inflammation caused by HBV in the host hepatocytes.
Adane Adugna   +2 more
wiley   +1 more source

Hepatitis B Vaccine Refusal Trends in Washington, DC, Newborns, 2017-2022.

open access: yesJAMA Netw Open
Yang YT, Leslie TF, Delamater PL.
europepmc   +1 more source

Home - About - Disclaimer - Privacy